Narendranath Epperla, MBBS, MSThe James Cancer Center
I’m a hematologist specializing in treating non-Hodgkin lymphoma, Hodgkin lymphoma and other blood cancers. I serve as an assistant professor in Internal Medicine at The Ohio State University.
My research focuses on conducting clinical trials using novel drug combinations to treat patients with lymphoid malignancies. In addition, my focus also entails to identify possible biomarkers that can predict treatment response. My research has been published in numerous journals, including Cancer, the Journal of Hematology and Oncology, British Journal of Hematology and the American Journal of Hematology. I have received several awards during my residency and fellowship, as well as honors from American Society of Clinical Oncology and American Society of Blood and Marrow Transplantation.
I’ve always aspired to be a complete physician by providing quality care to my patients, completing impactful research on their diseases and mentoring students. The OSUCCC – James gives me the platform to accomplish this mission and provides the opportunity to work with deeply experienced colleagues. I’m hopeful that the combination of high-quality research, state-of-the-art technology and targeted treatment plans will help us achieve our goal of a cancer-free world.
Education and Background
Kamineni Institute of Medical Sciences
MARSHFIELD, United States
Medical College of Wisconsin Affiliated Hospitals
- American Board of Internal Medicine
- Department of Internal Medicine
- Division of Hematology
I see patients at
The James Cancer Hospital and Solove Research Institute
460 West 10th Avenue, Columbus, Ohio 43210
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Epperla has reported no financial relationships with medical device, research and/or drug companies.